NO20013440L - Sammensetninger med forbedret stabilitet - Google Patents

Sammensetninger med forbedret stabilitet

Info

Publication number
NO20013440L
NO20013440L NO20013440A NO20013440A NO20013440L NO 20013440 L NO20013440 L NO 20013440L NO 20013440 A NO20013440 A NO 20013440A NO 20013440 A NO20013440 A NO 20013440A NO 20013440 L NO20013440 L NO 20013440L
Authority
NO
Norway
Prior art keywords
compositions
improved stability
stability
improved
Prior art date
Application number
NO20013440A
Other languages
English (en)
Norwegian (no)
Other versions
NO20013440D0 (no
Inventor
Douglas Joseph Dobrozsi
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of NO20013440D0 publication Critical patent/NO20013440D0/no
Publication of NO20013440L publication Critical patent/NO20013440L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
NO20013440A 1999-01-11 2001-07-11 Sammensetninger med forbedret stabilitet NO20013440L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11537899P 1999-01-11 1999-01-11
US15653999P 1999-09-29 1999-09-29
PCT/US2000/000574 WO2000041692A2 (en) 1999-01-11 2000-01-10 Compositions having improved stability

Publications (2)

Publication Number Publication Date
NO20013440D0 NO20013440D0 (no) 2001-07-11
NO20013440L true NO20013440L (no) 2001-09-11

Family

ID=26813132

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20013440A NO20013440L (no) 1999-01-11 2001-07-11 Sammensetninger med forbedret stabilitet

Country Status (16)

Country Link
US (1) US20020086878A1 (pt)
EP (1) EP1143973A2 (pt)
JP (1) JP2002534462A (pt)
KR (1) KR20010093256A (pt)
CN (1) CN1346270A (pt)
AU (1) AU3344900A (pt)
BR (1) BR0007428A (pt)
CA (1) CA2360358A1 (pt)
CO (1) CO5430216A1 (pt)
CZ (1) CZ20012493A3 (pt)
HU (1) HUP0105279A3 (pt)
ID (1) ID30508A (pt)
NO (1) NO20013440L (pt)
PE (1) PE20001397A1 (pt)
TR (1) TR200101929T2 (pt)
WO (1) WO2000041692A2 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60309440T2 (de) 2002-02-08 2007-10-11 The Procter & Gamble Company, Cincinnati Kindersichere verpackung
US20040028622A1 (en) * 2002-08-12 2004-02-12 Michael Gurin Multifunctional flavor systems and method of use
SI2218448T1 (sl) 2002-12-13 2016-01-29 Durect Corporation Sistem za oralno dajanje zdravila, ki obsega tekoči nosilec materialov z visoko viskoznostjo
JP4542743B2 (ja) * 2002-12-26 2010-09-15 Ｋｄｌ株式会社 ピリドン誘導体の溶液状医薬組成物
US20070048424A1 (en) * 2005-09-01 2007-03-01 Moza Ashok K Liquid composition of 2-Isopropyl-N,2,3-trimethylbutyramide and N-Ethyl-p-menthane-3-carboxamide, its preparation method and its applications as a cooling agent and flavor enhancer
US20070059417A1 (en) * 2005-09-15 2007-03-15 Moza Ashok K Cooling agents as flavor and saltiness enhancers
FR2906140B1 (fr) * 2006-09-22 2008-12-05 Philippe Perovitch Forme galenique pour l'administration par voie trans-muqueuse de principes actifs
FR2910317B1 (fr) * 2006-12-21 2009-02-13 Philippe Perovitch Forme galenique pour l'administration par voie transmuqueuse de paracetamol
AU2008347158B8 (en) 2007-12-06 2013-08-22 Durect Corporation Oral pharmaceutical dosage forms
US20100260844A1 (en) 2008-11-03 2010-10-14 Scicinski Jan J Oral pharmaceutical dosage forms
US8518439B2 (en) * 2008-12-03 2013-08-27 Novartis Ag Liquid therapeutic composition
EP2983468A4 (en) 2013-03-15 2016-09-07 Durect Corp COMPOSITIONS WITH RHEOLOGY MODIFIER TO REDUCE RESOLUTION VARIABILITY
WO2018183203A1 (en) * 2017-03-27 2018-10-04 DXM Pharmaceutical, Inc. Packaged multi-dose liquid drug formulation
US11234897B2 (en) 2017-03-27 2022-02-01 DXM Pharmaceutical, Inc. Packaged multi-dose liquid dextromethorphan hydrobromide formulation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5100898A (en) * 1990-01-25 1992-03-31 Richardson-Vicks Inc. Antitussive liquid compositions containing dyclonine
SK96196A3 (en) * 1994-01-24 1997-03-05 Procter & Gamble Process for solubilizing difficultly soluble pharmaceutical actives
US5510389A (en) * 1994-03-02 1996-04-23 The Procter & Gamble Company Concentrated acetaminophen solution compositions
US5616621A (en) * 1995-01-30 1997-04-01 American Home Products Corporation Taste masking liquids

Also Published As

Publication number Publication date
AU3344900A (en) 2000-08-01
CN1346270A (zh) 2002-04-24
WO2000041692A2 (en) 2000-07-20
EP1143973A2 (en) 2001-10-17
BR0007428A (pt) 2002-10-15
WO2000041692A3 (en) 2000-11-30
KR20010093256A (ko) 2001-10-27
PE20001397A1 (es) 2000-12-21
TR200101929T2 (tr) 2001-12-21
HUP0105279A2 (hu) 2002-05-29
CA2360358A1 (en) 2000-07-20
ID30508A (id) 2001-12-13
CO5430216A1 (es) 2004-06-01
US20020086878A1 (en) 2002-07-04
CZ20012493A3 (cs) 2001-11-14
JP2002534462A (ja) 2002-10-15
HUP0105279A3 (en) 2003-05-28
NO20013440D0 (no) 2001-07-11

Similar Documents

Publication Publication Date Title
IS6120A (is) Lyfjablanda
AR023440A1 (es) Composiciones antitranspirantes
NO20021116D0 (no) Ny sammensetning
EE200100420A (et) Kütusekoostis
ATE490327T1 (de) Impfstoffzusammensetzung
DE60000944D1 (de) Bohrlochzementzusammensetzungen
IS2932B (is) Fúlvestrant samsetning
DE60025198D1 (de) Stabile biozidale zusammensetzung
ID29785A (id) Komposisi-komposisi sampo
NO20021115L (no) Ny sammensetning
DE60007731D1 (de) Schweisshemmende zusammensetzungen
ATE295081T1 (de) Hilfsstoff-zusammensetzung
DE69943245D1 (de) Gaserzeugende zusammensetzung
DE60016836D1 (de) Resistzusammensetzung
NO20013440L (no) Sammensetninger med forbedret stabilitet
DE60116858D1 (de) Zusammensetzung
DE60023481D1 (de) Injizierbare zusammensetzung
DK199901730A (da) Ny Sammensætning
DE60020682D1 (de) Resorcinenthaltende zusammensetzung
DE60030095D1 (de) Reinigungsmittel-zusammensetzung
ID27329A (id) Komposisi penghambat
NO20022845L (no) Limsammensetning
DE60005188D1 (de) Grf-haltige lyophilisierte arzneizusammensetzungen
ID30320A (id) Komposisi-komposisi berpigmen
DE60029780D1 (de) Biozide zusammensetzungen

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application